CN101928292A - 头孢呋辛酸的制备方法 - Google Patents
头孢呋辛酸的制备方法 Download PDFInfo
- Publication number
- CN101928292A CN101928292A CN 201010285976 CN201010285976A CN101928292A CN 101928292 A CN101928292 A CN 101928292A CN 201010285976 CN201010285976 CN 201010285976 CN 201010285976 A CN201010285976 A CN 201010285976A CN 101928292 A CN101928292 A CN 101928292A
- Authority
- CN
- China
- Prior art keywords
- preferred
- hydrolysis
- acid
- cefuroxime acid
- cefuroxime
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960001668 cefuroxime Drugs 0.000 title claims abstract description 45
- JFPVXVDWJQMJEE-IZRZKJBUSA-N cefuroxime Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 JFPVXVDWJQMJEE-IZRZKJBUSA-N 0.000 title claims abstract description 43
- 238000000034 method Methods 0.000 title claims abstract description 22
- OUSLHGWWWMRAIG-FBCAJUAOSA-N (6r,7r)-7-[[(2z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound N([C@@H]1C(N2C(=C(CO)CS[C@@H]21)C(O)=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 OUSLHGWWWMRAIG-FBCAJUAOSA-N 0.000 claims abstract description 25
- HSHGZXNAXBPPDL-HZGVNTEJSA-N 7beta-aminocephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@@H]12 HSHGZXNAXBPPDL-HZGVNTEJSA-N 0.000 claims abstract description 25
- 238000002360 preparation method Methods 0.000 claims abstract description 23
- 238000006243 chemical reaction Methods 0.000 claims abstract description 22
- -1 chlorosulfonyl cefuroxime Chemical compound 0.000 claims abstract description 19
- 230000002829 reductive effect Effects 0.000 claims abstract description 11
- WRJWRGBVPUUDLA-UHFFFAOYSA-N chlorosulfonyl isocyanate Chemical compound ClS(=O)(=O)N=C=O WRJWRGBVPUUDLA-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000007864 aqueous solution Substances 0.000 claims abstract description 7
- 238000005917 acylation reaction Methods 0.000 claims abstract description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 45
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 38
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 34
- 230000007062 hydrolysis Effects 0.000 claims description 23
- 238000006460 hydrolysis reaction Methods 0.000 claims description 23
- 238000002425 crystallisation Methods 0.000 claims description 19
- 230000008025 crystallization Effects 0.000 claims description 18
- 239000000243 solution Substances 0.000 claims description 18
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 13
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 12
- 239000003513 alkali Substances 0.000 claims description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 11
- 150000001263 acyl chlorides Chemical class 0.000 claims description 11
- IXQPRUQVJIJUEB-UHFFFAOYSA-N 7-(diethylamino)-n-[2-(2,5-dioxopyrrol-1-yl)ethyl]-2-oxochromene-3-carboxamide Chemical compound O=C1OC2=CC(N(CC)CC)=CC=C2C=C1C(=O)NCCN1C(=O)C=CC1=O IXQPRUQVJIJUEB-UHFFFAOYSA-N 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 claims description 9
- 238000005957 chlorosulfonylation reaction Methods 0.000 claims description 9
- 239000012046 mixed solvent Substances 0.000 claims description 9
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 claims description 9
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 claims description 9
- 235000010262 sodium metabisulphite Nutrition 0.000 claims description 9
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 8
- 239000012752 auxiliary agent Substances 0.000 claims description 8
- 239000013078 crystal Substances 0.000 claims description 8
- GRWZHXKQBITJKP-UHFFFAOYSA-N dithionous acid Chemical compound OS(=O)S(O)=O GRWZHXKQBITJKP-UHFFFAOYSA-N 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 6
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 6
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 claims description 6
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 claims description 5
- AVGQTJUPLKNPQP-UHFFFAOYSA-N 1,1,1-trichloropropane Chemical compound CCC(Cl)(Cl)Cl AVGQTJUPLKNPQP-UHFFFAOYSA-N 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 102000004190 Enzymes Human genes 0.000 claims description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 5
- 229930182555 Penicillin Natural products 0.000 claims description 5
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 5
- 239000007810 chemical reaction solvent Substances 0.000 claims description 5
- 229940049954 penicillin Drugs 0.000 claims description 5
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 claims description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 4
- 230000006181 N-acylation Effects 0.000 claims description 4
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 4
- 239000008139 complexing agent Substances 0.000 claims description 4
- 235000017550 sodium carbonate Nutrition 0.000 claims description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 4
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical group [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 claims description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 2
- 150000003863 ammonium salts Chemical class 0.000 claims description 2
- 239000001103 potassium chloride Substances 0.000 claims description 2
- 235000011164 potassium chloride Nutrition 0.000 claims description 2
- 159000000000 sodium salts Chemical group 0.000 claims description 2
- 239000002994 raw material Substances 0.000 abstract description 4
- 238000005935 nucleophilic addition reaction Methods 0.000 abstract description 3
- 239000003960 organic solvent Substances 0.000 abstract description 3
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- LVYGIENTBXRNOU-UHFFFAOYSA-N acetic acid N-methoxy-3H-furan-2-imine Chemical compound C(C)(=O)O.CON=C1OC=CC1 LVYGIENTBXRNOU-UHFFFAOYSA-N 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 239000003086 colorant Substances 0.000 abstract 1
- 230000006196 deacetylation Effects 0.000 abstract 1
- 238000003381 deacetylation reaction Methods 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 238000003756 stirring Methods 0.000 description 31
- 238000005406 washing Methods 0.000 description 18
- 239000012074 organic phase Substances 0.000 description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- 239000000047 product Substances 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000012065 filter cake Substances 0.000 description 8
- 238000001035 drying Methods 0.000 description 6
- 230000004580 weight loss Effects 0.000 description 6
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 5
- 239000012670 alkaline solution Substances 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- CXHHBNMLPJOKQD-UHFFFAOYSA-M methyl carbonate Chemical compound COC([O-])=O CXHHBNMLPJOKQD-UHFFFAOYSA-M 0.000 description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 238000002386 leaching Methods 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 238000001291 vacuum drying Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 3
- 238000010009 beating Methods 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 239000001632 sodium acetate Substances 0.000 description 3
- 235000017281 sodium acetate Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 229930186147 Cephalosporin Natural products 0.000 description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- 229940124587 cephalosporin Drugs 0.000 description 2
- 150000001780 cephalosporins Chemical class 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- QALUUCSIORXIHV-UHFFFAOYSA-N 3-methoxy-3H-furan-2-imine Chemical class COC1C(OC=C1)=N QALUUCSIORXIHV-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
- ODFJOVXVLFUVNQ-UHFFFAOYSA-N acetarsol Chemical compound CC(=O)NC1=CC([As](O)(O)=O)=CC=C1O ODFJOVXVLFUVNQ-UHFFFAOYSA-N 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000021235 carbamoylation Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Substances OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Landscapes
- Cephalosporin Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010285976 CN101928292B (zh) | 2010-09-19 | 2010-09-19 | 头孢呋辛酸的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010285976 CN101928292B (zh) | 2010-09-19 | 2010-09-19 | 头孢呋辛酸的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101928292A true CN101928292A (zh) | 2010-12-29 |
CN101928292B CN101928292B (zh) | 2013-03-13 |
Family
ID=43367766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010285976 Expired - Fee Related CN101928292B (zh) | 2010-09-19 | 2010-09-19 | 头孢呋辛酸的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101928292B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102702231A (zh) * | 2012-06-18 | 2012-10-03 | 山东大学 | 一种3-去氨甲酰基-头孢呋辛酸的制备方法 |
CN103073563A (zh) * | 2013-01-23 | 2013-05-01 | 海南通用三洋药业有限公司 | 一种头孢替坦二钠的制备方法 |
CN104072516A (zh) * | 2014-06-18 | 2014-10-01 | 珠海保税区丽珠合成制药有限公司 | 一种合成头孢呋辛酸的方法 |
CN106432267A (zh) * | 2016-08-28 | 2017-02-22 | 珠海保税区丽珠合成制药有限公司 | 一种头孢呋辛酸的制备方法 |
CN106478667A (zh) * | 2016-08-31 | 2017-03-08 | 河北科技大学 | 一种3‑去氨甲酰基‑头孢呋辛酸结晶的制备工艺 |
CN106478668A (zh) * | 2016-08-31 | 2017-03-08 | 河北科技大学 | 一种头孢呋辛酸结晶的制备工艺 |
CN112574232A (zh) * | 2020-12-29 | 2021-03-30 | 山东金城昆仑药业有限公司 | 从头孢呋辛酸废渣液中回收头孢呋辛酸的方法 |
WO2021232694A1 (zh) * | 2020-05-22 | 2021-11-25 | 山东金城柯瑞化学有限公司 | 一种镍基催化合成3-去氨甲酰基头孢呋辛酸的方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006103686A1 (en) * | 2005-03-29 | 2006-10-05 | Hetero Drugs Limited | An improved process for the preparation of cefixime |
CN101016305A (zh) * | 2007-02-12 | 2007-08-15 | 河源市制药工程技术研究开发中心 | 一种头孢克肟的合成方法 |
CN101289456A (zh) * | 2008-06-07 | 2008-10-22 | 沂源鑫泉化工有限公司 | 头孢呋辛酸的合成方法 |
CN101289457A (zh) * | 2008-06-13 | 2008-10-22 | 河源市制药工程技术研究开发中心 | 3-去乙酰基头孢呋辛酸(dccf)合成新工艺 |
CN101337969A (zh) * | 2008-08-12 | 2009-01-07 | 苏州万庆药业有限公司 | 一种抗菌素头孢克肟的合成方法 |
-
2010
- 2010-09-19 CN CN 201010285976 patent/CN101928292B/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006103686A1 (en) * | 2005-03-29 | 2006-10-05 | Hetero Drugs Limited | An improved process for the preparation of cefixime |
CN101016305A (zh) * | 2007-02-12 | 2007-08-15 | 河源市制药工程技术研究开发中心 | 一种头孢克肟的合成方法 |
CN101289456A (zh) * | 2008-06-07 | 2008-10-22 | 沂源鑫泉化工有限公司 | 头孢呋辛酸的合成方法 |
CN101289457A (zh) * | 2008-06-13 | 2008-10-22 | 河源市制药工程技术研究开发中心 | 3-去乙酰基头孢呋辛酸(dccf)合成新工艺 |
CN101337969A (zh) * | 2008-08-12 | 2009-01-07 | 苏州万庆药业有限公司 | 一种抗菌素头孢克肟的合成方法 |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102702231A (zh) * | 2012-06-18 | 2012-10-03 | 山东大学 | 一种3-去氨甲酰基-头孢呋辛酸的制备方法 |
CN102702231B (zh) * | 2012-06-18 | 2014-10-29 | 山东大学 | 一种3-去氨甲酰基-头孢呋辛酸的制备方法 |
CN103073563A (zh) * | 2013-01-23 | 2013-05-01 | 海南通用三洋药业有限公司 | 一种头孢替坦二钠的制备方法 |
CN104072516A (zh) * | 2014-06-18 | 2014-10-01 | 珠海保税区丽珠合成制药有限公司 | 一种合成头孢呋辛酸的方法 |
CN106432267A (zh) * | 2016-08-28 | 2017-02-22 | 珠海保税区丽珠合成制药有限公司 | 一种头孢呋辛酸的制备方法 |
CN106478667A (zh) * | 2016-08-31 | 2017-03-08 | 河北科技大学 | 一种3‑去氨甲酰基‑头孢呋辛酸结晶的制备工艺 |
CN106478668A (zh) * | 2016-08-31 | 2017-03-08 | 河北科技大学 | 一种头孢呋辛酸结晶的制备工艺 |
WO2021232694A1 (zh) * | 2020-05-22 | 2021-11-25 | 山东金城柯瑞化学有限公司 | 一种镍基催化合成3-去氨甲酰基头孢呋辛酸的方法 |
CN112574232A (zh) * | 2020-12-29 | 2021-03-30 | 山东金城昆仑药业有限公司 | 从头孢呋辛酸废渣液中回收头孢呋辛酸的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101928292B (zh) | 2013-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101928292B (zh) | 头孢呋辛酸的制备方法 | |
CN100564382C (zh) | 头孢呋辛钠的合成方法 | |
CN101648961B (zh) | 一种制备头孢替安盐酸盐的方法及设备 | |
CN101538255B (zh) | 2-甲氧基亚氨基2-呋喃乙酸胺的制备方法 | |
CN101007812A (zh) | 抗菌药物头孢西丁的制备工艺 | |
CN102134252A (zh) | 一种高纯头孢呋辛酸的制备方法 | |
CN103319502B (zh) | 一种磺苄西林钠的制备方法 | |
CN104356146A (zh) | 一种头孢替安盐酸盐的制备方法 | |
CN105131017A (zh) | 一种盐酸头孢卡品酯的制备方法 | |
CN104193765B (zh) | 一种头孢克肟的合成方法 | |
CN102702231B (zh) | 一种3-去氨甲酰基-头孢呋辛酸的制备方法 | |
CN103319503A (zh) | 一种头孢地尼的制备方法 | |
CN104447800A (zh) | 一种头孢西丁酸的合成技术 | |
CN107266473B (zh) | 一种头孢他啶的合成方法 | |
ITMI20071951A1 (it) | Processo per la produzione di 7-metossi-3-desacetilcefalotina | |
CN109485658A (zh) | 一种头孢替唑酸的制备方法 | |
CN108101812A (zh) | 一种月桂酰精氨酸乙酯盐酸盐的生产纯化工艺 | |
CN102559829A (zh) | 头孢曲松钠粗盐的合成方法 | |
CN110407857B (zh) | 一种头孢硫脒的制备工艺 | |
CN110117291B (zh) | 一种头孢噻肟酸的合成方法 | |
CN107892676B (zh) | 头孢地尼活性硫酯的制备方法 | |
CN109517002B (zh) | 一种盐酸头孢替安的合成方法 | |
CN102093390B (zh) | 一种制备头孢呋辛酸的方法 | |
CN111471057A (zh) | 一种溶媒结晶制备美洛西林钠的工艺 | |
CN1958591B (zh) | 头孢菌素类中间体的制备方法及头孢唑肟丙匹酯的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: SINOPHARM GROUP ZHIJUN (SUZHOU) PHARMACEUTICAL CO. Free format text: FORMER NAME: SUZHOU ZHIJUN WANQING PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 215415 Taicang Regal Economic Development Zone, Jiangsu Patentee after: SINOPHARM ZHIJUN (SUZHOU) PHARMACEUTICAL CO.,LTD. Address before: 215415 Taicang Regal Economic Development Zone, Jiangsu Patentee before: SUZHOU ZHIJUN WANQING PHARMACEUTICAL Co.,Ltd. |
|
PP01 | Preservation of patent right |
Effective date of registration: 20200410 Granted publication date: 20130313 |
|
PP01 | Preservation of patent right | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20230410 Granted publication date: 20130313 |
|
PD01 | Discharge of preservation of patent | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130313 |
|
CF01 | Termination of patent right due to non-payment of annual fee |